Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Prospective Registry of Patients With Alpha Thalassemia

NCT04872179 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT04872179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04872179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Prospective Registry of Patients With Alpha Thalassemia
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Recruiting
Start date
January 31, 2017
Completion date
January 31, 2037
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alpha thalassemia major, alpha thalassemia minor, alpha-thalassemia